Comparison Between TICL and ICL+AK for High Myopic Astigmatism

Sponsor
Wenzhou Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT03202485
Collaborator
(none)
62
2
34

Study Details

Study Description

Brief Summary

To compare the outcomes of a toric Implantable Collamer Lens (ICL) and a spherical Implantable Collamer Lens combined with astigmatic keratotomy (AK) in the correction of high myopic astigmatism.

Condition or Disease Intervention/Treatment Phase
  • Device: Toric Implantable Collamer Lens
  • Device: ICL + Astigmatic keratotomy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
62 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Prospective comparative case seriesProspective comparative case series
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison Between Toric and Spherical Implantable Collamer Lens Combined With Astigmatic Keratotomy for High Myopic Astigmatism
Actual Study Start Date :
Mar 3, 2014
Actual Primary Completion Date :
Mar 2, 2015
Actual Study Completion Date :
Jan 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Toric Implantable Collamer Lens

Subjects in this group will implant Toric Implantable Collamer Lens for high myopic astigmatism

Device: Toric Implantable Collamer Lens
uses Toric Implantable Collamer Lens implantation to correct the high myopic astigmatism.

Experimental: ICL+ Astigmatic keratotomy

Subjects in this group will implant Implantable Collamer Lens and combined with astigmatic keratotomy for high myopic astigmatism

Device: ICL + Astigmatic keratotomy
uses Implantable Collamer Lens implantation combined with Astigmatic keratotomy to correct the high myopic astigmatism

Outcome Measures

Primary Outcome Measures

  1. Uncorrected Visual Acuity (UCVA) at distance [2 years after surgery]

    measured at 5 meter

  2. astigmatism [2 years after surgery]

    astigmatism getting from subjective refraction

Secondary Outcome Measures

  1. Best Corrected Visual Acuity (BCVA) at distance [2 years after surgery]

    subjective refraction

  2. Spherical Equivalent (SE) [2 years after surgery]

    subjective refraction

  3. mean postoperative BCVA/mean preoperative BCVA [2 years after surgery]

    safety index

  4. mean postoperative UCVA/mean preoperative BCVA [2 years after surgery]

    efficacy index

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • age ranged from 18 to 40 years,

  • myopia greater than -8.00 diopters (D), and refractive cylinder in the range of 1.50D to 5.50D,

  • for the patients who were planned to undergo AK+ICL implantation, the axial difference between the corneal astigmatism and the manifest refractive astigmatism was less than 10 degree,

  • a stable refractive error during the previous 2 years,

  • anterior chamber depth more than 2.8 mm,

  • endothelial cell density (ECD) more than 2500 cells/mm2, and

  • scotopic pupillary diameter less than 7 mm.

Exclusion Criteria:
  • subjects had significant irregular astigmatism, corneal pathological changes, glaucoma, ocular inflammation, or previous ocular trauma or surgery.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Wenzhou Medical University

Investigators

  • Principal Investigator: AYong Yu, MD.PhD., Wenzhou Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
A-Yong Yu, vice director of refractive surgery department of the eye hospital of WZMU, Wenzhou Medical University
ClinicalTrials.gov Identifier:
NCT03202485
Other Study ID Numbers:
  • TICL compare with ICL+AK
First Posted:
Jun 28, 2017
Last Update Posted:
Jun 28, 2017
Last Verified:
Jun 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by A-Yong Yu, vice director of refractive surgery department of the eye hospital of WZMU, Wenzhou Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 28, 2017